— Know what they know.
Not Investment Advice

ANAB NASDAQ

AnaptysBio, Inc.
1W: -6.2% 1M: -5.5% 3M: -0.7% YTD: +19.8% 1Y: +136.5% 3Y: +170.4% 5Y: +104.9%
$53.87
-1.29 (-2.34%)
 
Weekly Expected Move ±4.7%
$49 $51 $54 $56 $59
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 40 · $1.6B mcap · 28M float · 2.15% daily turnover · Short 63% of daily vol
Last Earnings 2026-09-09
EPS
$-0.31
▲ Beat +25.0%
Revenue
$7M
Est (actual pending)
EPS Beat Streak: 7 quarters
Next Earnings 2026-11-10
EPS Estimate
$-0.05
Range: $-0.28 - $0.04
Revenue Estimate
$16M
4 analysts

Estimate vs Actual

Earnings Surprise History

10/18
EPS Beats
12/18
Revenue Beats
56%
EPS Beat Rate
67%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-09-11 annual 2028-12-31 $5.47 $6.27 ▲ 0.80 $331,541,633 $314,673,762
2026-09-11 quarter 2026-12-31 $0.02 $0.02 $10,423,333 $20,322,414
2026-09-11 annual 2026-12-31 $-2.28 $-2.28 $68,478,000 $92,901,259
2026-09-11 quarter 2026-09-30 $-0.05 $-0.05 $9,296,667 $16,128,155
2026-09-11 quarter 2026-06-30 $-0.47 $-0.47 $8,893,333 $14,057,374
2026-09-11 annual 2027-12-31 $2.86 $2.86 $136,160,667 $158,486,157
2026-09-04 quarter 2026-09-30 $-0.06 $-0.05 ▲ 0.01 $6,972,500 $9,296,667
2026-09-04 quarter 2026-12-31 $-0.01 $0.02 ▲ 0.03 $7,817,500 $10,423,333
2026-09-04 quarter 2026-06-30 $-0.41 $-0.47 ▼ 0.05 $6,670,000 $8,893,333
2026-09-04 annual 2026-12-31 $-2.07 $-2.28 ▼ 0.21 $54,185,333 $68,478,000
2026-09-04 annual 2027-12-31 $1.41 $2.86 ▲ 1.46 $103,920,500 $136,160,667
2026-09-04 annual 2029-12-31 $6.40 $5.90 ▼ 0.50 $332,278,950 $350,005,267
2026-09-04 annual 2030-12-31 $7.33 $6.64 ▼ 0.69 $366,027,333 $385,441,000
2026-09-04 annual 2028-12-31 $5.65 $5.47 ▼ 0.18 $305,731,225 $331,541,633
2026-09-01 annual 2026-12-31 $-2.07 $-2.07 $40,639,000 $54,185,333
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms